Taiwan FDA to set consumption limits on ashwagandha and seven other botanicals By Tingmin Koe 05-Sep-2023 - Last updated on 05-Sep-2023 at 11:26 GMT Facebook Twitter Linkedin Email to a friend Taiwan’s Food and Drug Administration will be setting consumption limits and usage warnings on ashwagandha and seven other botanicals that are used as food ingredients.Read the full story here. NIA top 10 stories Exclusive China analysis: Consumers spending cautiously but supplement sector holding up well Great expectations: Kirin targeting Blackmores to hit 100bn yen revenue, 15% profit margin ASEAN health supplements harmonisation delayed once again, but firms eyeing SEA advised to adopt standards Japan’s functional food insights: Sleep, stress and skin health claims on the rise – exclusive data Taiwan FDA to set consumption limits on ashwagandha and seven other botanicals Asia Pacific growth offsets US’s VMS revenue decline – Centrum, Caltrate maker Haleon Danone H1 results: Aptamil delivers ‘solid growth’ while Mizone recovers from underperformance in China Growth agenda: India’s nutraceutical market opportunities ‘far bigger’ than the pharma sector Calorie crash: Kirin launches immune care postbiotic drink in Japan with 50% less calories South Korea reviews regulations for nine ingredients, including oat fibre, CoQ10, inulin Prev 1 … 4 5 6 7 8 … 11 Next